Mentice AB Total Liabilities

Latest as of June 2026: Skr174.93 Million SEK ≈ $18.83 Million USD

Mentice AB total liabilities. Based on the latest financial reports, Mentice AB (MNTC) has total liabilities worth Skr174.93 Million SEK (≈ $18.83 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of Mentice AB to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Mentice AB (2017–2025)

Total liabilities of Mentice AB from 2017 to 2025. This chart illustrates how Mentice AB's total liabilities have evolved over time, based on quarterly financial data.

Mentice AB Competitors by Total Liabilities

The table below lists competitors of Mentice AB ranked by their total liabilities.

Company Country Total Liabilities
Hikma Pharmaceuticals PLC
LSE:HIK
UK GBX3.00 Billion
Aeye Inc
NASDAQ:LIDR
USA $8.26 Million
Chemfab Alkalis Limited
NSE:CHEMFAB
India Rs1.88 Billion
Sarveshwar Foods Limited
NSE:SARVESHWAR
India Rs6.64 Billion
Werewolf Therapeutics Inc
NASDAQ:HOWL
USA $7.86 Million
Ramaco Resources Inc.
NASDAQ:METCB
USA $654.58 Million
seha corporation
KO:027970
Korea ₩335.88 Billion
Kodiak Copper Corp
V:KDK
Canada CA$5.11 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Mentice AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MNTC total assets.

Liquidity & Leverage Metrics

Mentice AB Total Liabilities Ratios Explained

Mentice AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.00 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.42 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.59 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mentice AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mentice AB (2017–2025)

The table below shows the annual total liabilities of Mentice AB from 2017 to 2025.

Year Total Liabilities Change
2025-12-31 Skr173.65 Million
≈ $18.69 Million
-3.66%
2024-12-31 Skr180.24 Million
≈ $19.40 Million
+10.20%
2023-12-31 Skr163.55 Million
≈ $17.60 Million
-3.98%
2022-12-31 Skr170.34 Million
≈ $18.33 Million
+36.25%
2021-12-31 Skr125.02 Million
≈ $13.45 Million
+52.42%
2020-12-31 Skr82.02 Million
≈ $8.83 Million
+31.49%
2019-12-31 Skr62.38 Million
≈ $6.71 Million
-2.31%
2018-12-31 Skr63.85 Million
≈ $6.87 Million
+41.32%
2017-12-31 Skr45.18 Million
≈ $4.86 Million
--

About Mentice AB

ST:MNTC Sweden Medical Devices
Market Cap
$46.92 Million
Skr435.95 Million SEK
Market Cap Rank
#21940 Global
#412 in Sweden
Share Price
Skr15.50
Change (1 day)
-1.27%
52-Week Range
Skr9.38 - Skr17.10
All Time High
Skr184.50
About

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedura… Read more